Skip to main content
eScholarship
Open Access Publications from the University of California

Tubular cell and keratinocyte single-cell transcriptomics applied to lupus nephritis reveal type I IFN and fibrosis relevant pathways.

  • Author(s): Der, Evan
  • Suryawanshi, Hemant
  • Morozov, Pavel
  • Kustagi, Manjunath
  • Goilav, Beatrice
  • Ranabothu, Saritha
  • Izmirly, Peter
  • Clancy, Robert
  • Belmont, H Michael
  • Koenigsberg, Mordecai
  • Mokrzycki, Michele
  • Rominieki, Helen
  • Graham, Jay A
  • Rocca, Juan P
  • Bornkamp, Nicole
  • Jordan, Nicole
  • Schulte, Emma
  • Wu, Ming
  • Pullman, James
  • Slowikowski, Kamil
  • Raychaudhuri, Soumya
  • Guthridge, Joel
  • James, Judith
  • Buyon, Jill
  • Tuschl, Thomas
  • Putterman, Chaim
  • Accelerating Medicines Partnership Rheumatoid Arthritis and Systemic Lupus Erythematosus (AMP RA/SLE) Consortium
  • et al.
Abstract

The molecular and cellular processes that lead to renal damage and to the heterogeneity of lupus nephritis (LN) are not well understood. We applied single-cell RNA sequencing (scRNA-seq) to renal biopsies from patients with LN and evaluated skin biopsies as a potential source of diagnostic and prognostic markers of renal disease. Type I interferon (IFN)-response signatures in tubular cells and keratinocytes distinguished patients with LN from healthy control subjects. Moreover, a high IFN-response signature and fibrotic signature in tubular cells were each associated with failure to respond to treatment. Analysis of tubular cells from patients with proliferative, membranous and mixed LN indicated pathways relevant to inflammation and fibrosis, which offer insight into their histologic differences. In summary, we applied scRNA-seq to LN to deconstruct its heterogeneity and identify novel targets for personalized approaches to therapy.

Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.

Main Content
Current View